The American College of Cardiology (ACC) reported January 4, 2023, that new research on treatment of recurrent pericarditis involving cardiac magnetic resonance imaging and interlukin-1 inhibitors may ...

Please provide your email address to receive an email when new articles are posted on . Advances in imaging techniques and new treatments are changing the management of recurrent pericarditis, ...

Please provide your email address to receive an email when new articles are posted on . Acute and recurrent pericarditis require medical management to improve morbidity and quality of life. Aspirin, ...

Manage recurrent pericarditis with heart-healthy food swaps. Learn how a Mediterranean-style diet can reduce inflammation and ...

Learn how to prevent pericarditis flare-ups while traveling by managing your medications, conserving your energy, and ...

Sequence variants that protect against pericarditis have been discovered at a genomic locus encoding interleukin-1 immune cytokines. A newly approved drug treatment for pericarditis inhibits these ...

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers actively enrolling patients. Activation of additional top-tier clinical sites in Europe and ...

Sequence variants that protect against pericarditis have been discovered at a genomic locus encoding interleukin-1 immune cytokines. A newly approved drug treatment for pericarditis inhibits these ...

This is a Designated News Release. Toronto, Ontario--(Newsfile Corp. - February 15, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life ...

Credit: Getty Images A discussion on the new American Heart Association’s pericarditis initiative with Jimmy Kerrigan, MD. For the estimated 40,000 adults with recurrent pericarditis in the United ...

Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth –– ARCALYST 2026 expected net ...